Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

RepliCel Life Sciences Inc (OTCQB:REPCD)

0.4498
Delayed Data
As of Aug 22
 0.00 / 0.00%
Today’s Change
0.45
Today|||52-Week Range
3.10
-76.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.6K1.3K1.2K1.1K
 
 
 
 
 
 
Operating ExpensesGross Income-1.6K-1.3K-1.2K-1.1K
 
 
 
 
 
General Expenses1.1M899.3K971.4K795.6K
 
 
 
 
 
Research And Development506.2K438.9K488.6K271.5K
 
 
 
 
 
Total Operating Expenses1.1M900.6K972.6K796.7K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.1M-900.6K-972.6K-796.7K
 
 
 
 
 
Extraordinary Credit4.6K36.69426.110.00
 
 
 
 
Other Expenses-4.0K-4.6K-1.9K18.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.1M-905.1K-973.5K-778.7K
 
 
 
 
 
Net Income-1.1M-905.1K-973.5K-778.7K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.4M6.0M6.3M6.3M
 
 
 
 
 
Shares To Calculate EPS Diluted5.4M6.0M6.3M6.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.15-$0.15-$0.15
 
 
 
 
 
EPS Diluted-$0.24-$0.15-$0.15-$0.15